+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-10-10Number of Pages: 97

Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Table of Content

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

      3.1.1 Market Potential of Transcriptomics Technologies

      3.1.2 Future Scenario of Transcriptomics

      3.1.3 Market Dynamics

3.2 Market Drivers

      3.2.1 Technological Advancements

      3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)

      3.2.3 Increasing Research and Development Investments

      3.2.4 Impact Analysis of Market Drivers

3.3 Market Restraints

      3.3.1 Lack Of Efficient Data Analysis Tools

      3.3.2 Impact Analysis of Market Restraints

3.4 Market Opportunities

      3.4.1 Focus on Development of Bioinformatics Tools and Services

3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

      3.5.1 Bargaining Power Of Buyers

      3.5.2 Bargaining Power Of Suppliers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

 

Chapter 4 Global Transcriptomics Technologies Market, By Technology

4.1 Introduction

4.2 Microarrays

      4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.2 Polymerase Chain Reaction (PCR)

               4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.3 Gene Regulation Technologies (RNA Interference Technology)

              4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.4 Next Generation Sequencing (NGS)

              4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 5 Global Transcriptomics Technologies Market, By Application

5.1 Overview

5.2 Clinical Diagnostics

      5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.3 Drug Discovery And Research

      5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)

5.4 Bioinformatics

      5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.5 Comparative Transcriptome Studies

      5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 6 Global Transcriptomics Technologies Market, By Geography

6.1 Overview

      6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)

      6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

6.2 North America

      6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.5 Rest of the World (Row)

      6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 7 Competitive Landscape

7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

 

Chapter 8 Recommendations

8.1 Collaboration with Academic and Research Institutes

8.2 Focus on Imparting Education about Genomic Medicine

 

Chapter 9 Company Profiles

9.1 Affymetrix, Inc.

      9.1.1 Company Overview

      9.1.2 Financial Overview

      9.1.3 Product Portfolio

      9.1.4 Business Strategies

      9.1.5 Recent Developments

9.2 Agilent Technologies, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 Bio-Rad Laboratories, Inc.

      9.3.1 Business Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Danaher Corporation

      9.4.1 Business Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 F. Hoffmann-La Roche Ltd.

      9.5.1 Company Overview      

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 Illumina, Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Life Technologies Corporation

      9.7.1 Company Overview

      9.7.2 Financial Overview

      9.7.3 Product Portfolio

      9.7.4 Business Strategies

      9.7.5 Recent Developments

9.8 LC Sciences, LLC

      9.8.1 Company Overview

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 Qiagen N.V.

      9.9.1 Company Overview

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 Sigma-Aldrich Corporation

      9.10.1 Company Overview

      9.10.2 Financial Overview

      9.10.3 Product Portfolio

      9.10.4 Business Strategies

      9.10.5 Recent Developments

9.11 Thermo Fisher Scientific

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

      9.11.5 Recent Developments

List of Figures

 

FIG. 1 Central Dogma : Transcriptomics Technologies Market

FIG. 2 Transcriptomics Technologies: Market Segmentation

FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)

FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography

FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)

FIG. 20 Affymetrix, Inc., Annual Revenue:  2010 – 2012 (USD Million)

FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)

FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market

TABLE 3 Impact Analysis of Market Drivers

TABLE 4 Impact Analysis of Market Restraints

TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)

TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)

TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,     2011 – 2019(USD Million)


 
 
Back To Top